EUDAMED and eIFU: How to Register Your eIFU URL in the UDI Database
Registering your eIFU URL in EUDAMED is a legal duty, not a free text extra. Short answer: if you give instructions for use in electronic form instead of paper for an MDR device, Article 7(3) of Regulation (EU) 2021/2226, added by Regulation (EU) 2025/1234, requires you to enter the eIFU website address in the UDI database under Annex VI, Part B, point 22 of the MDR. The UDI/Device module has been mandatory since 28 May 2026, so a new device carries the address from its first registration. A device whose first unit reached the EU market before that date, and which is still being placed on the market, has until 28 November 2026. Matrix eIFU is the eIFU hosting service we build to keep that address stable.
A disclosure before the detail: I work at Matrix One, the company behind Matrix eIFU (formerly Dokspot), so read the product section with that in mind. Every article below was checked against the EUR-Lex texts on 10 November 2026, and every EUDAMED and swissdamed date against the European Commission and Swissmedic pages the same day.
This page was first written before the 28 May 2026 switch. It now covers what still has to be done. For the wider rulebook, read how to implement eIFU under EU 2025/1234 and our article by article record of what Regulations 2021/2226 and 2025/1234 changed.
What does the law require you to put in EUDAMED?
Article 7(3) of Regulation (EU) 2021/2226, as amended, says that at the latest from the date device registration in the UDI database applies under Article 123(3), point (d) or (e), of the MDR, the manufacturer shall provide the internet address referred to in Article 7(2), point (e), to the UDI database in accordance with Annex VI, Part B, point 22.
Point 22 of Annex VI, Part B reads "URL for additional information, such as electronic instructions for use (optional)". So the field is optional in the MDR itself. Article 7(3) is what makes it compulsory for a manufacturer that replaces paper with eIFU. The address you enter is the one printed under Article 6(2), the address on the label or packaging that users follow to reach the instructions.
What are the EUDAMED deadlines now that 28 May 2026 has passed?
| Date | What applies | Source |
|---|---|---|
| 27 November 2025 | Commission Decision (EU) 2025/2371 published in the Official Journal, declaring the first four EUDAMED modules functional. | European Commission EUDAMED overview |
| 28 May 2026 | Actor, UDI/Device, Notified Bodies and Certificates, and Market Surveillance modules mandatory to use. | Regulation (EU) 2024/1860; Commission EUDAMED overview |
| 1 July 2026 | Device registration mandatory in swissdamed, the Swiss database. | Swissmedic |
| 28 November 2026 | Deadline to register devices first placed on the EU market before 28 May 2026 and still being placed. | Commission transition timeline; EUDAMED Q&A |
| 31 December 2026 | End of the swissdamed device registration transition period. | Swissmedic |
The 28 November date comes from the Commission's Q&A on the gradual roll-out of EUDAMED: where the first unit of a legacy or Regulation device was placed on the EU market before mandatory use, and more units with the same UDI-DI follow, the device must be registered within 12 months of the notice's publication. The notice appeared on 27 November 2025, so the window closes on 28 November 2026. If that device ships with eIFU instead of paper, its eIFU address has to be in the record by then.
Which devices do not need a UDI/Device registration at all?
The same Q&A says legacy and Regulation devices whose units are no longer placed on the market when the module became mandatory do not need registering, unless a post-market surveillance or vigilance action occurs. A legacy device also needs no separate record when the same device is already registered as a Regulation device. For the UDI data model behind these records, see our UDI database guide and our EUDAMED overview.
Does the EUDAMED eIFU duty apply to every device?
No. Article 7(3) points to the Article 7(2) address, and Article 7(2) governs websites holding instructions given in electronic form instead of paper. Article 9 treats eIFU supplied in addition to complete paper instructions differently: it only has to be consistent with the paper version. As we read the text, a manufacturer that still ships full paper instructions keeps point 22 optional. Check that reading with your notified body before relying on it.
Regulation (EU) 2021/2226 is made under the MDR (Regulation (EU) 2017/745), and its Article 1 ties it to the MDR instructions for use. In vitro diagnostics follow the IVDR instead, so the Article 7(3) duty does not reach them. For IVD eIFU, read our guide to ISO 24884 and eIFU for IVDs.
How do you register your eIFU URL in EUDAMED, step by step?
For an MDR device that uses eIFU instead of paper, this order keeps each step building on the last:
Confirm your actor registration under MDR Article 31 and the single registration number it gives you, since device records hang off it.
Take the exact address printed on the label under Article 6(2) of 2021/2226. The EUDAMED entry and the label must match.
In the UDI/Device module, open the record for each UDI-DI and enter the address in the Annex VI, Part B, point 22 field, "URL for additional information".
Open the address from outside your company network, with no login, to prove it is directly accessible as Article 7(2)(e) requires.
Repeat for every UDI-DI still being placed on the market, finishing devices sold before 28 May 2026 by 28 November 2026.
Put the address under change control, and update every affected record if it ever changes.
What makes an eIFU address "stable and directly accessible"?
Article 7(2)(e) requires the address to be stable and directly accessible for the periods in Article 5, points (9) and (10). For devices with an expiry date, other than implants, that is 10 years after the last device is placed on the market and at least 2 years after the expiry date of the last device produced. For devices without an expiry date and for implantable devices, it is 15 years after the last device is placed on the market.
The earlier version of this page said a few years after withdrawal. The text sets 10 or 15 years, which is why the domain matters more than the document path. Register a company-controlled portal address on HTTPS, not a link shortener and not a direct link to one PDF that moves with every revision. A domain migration or rebrand then needs redirects planned years ahead, not a scramble.
What are the common mistakes with the EUDAMED eIFU field?
Is there a grace period after 28 May 2026?
Only for devices already on the market before that date: their registration window runs to 28 November 2026 under the Commission's Q&A. A device first placed on the market after 28 May 2026 is registered before it is placed, address included.
Do we need a separate URL for every device?
The regulation asks for a stable, directly accessible address, not one per device. Many manufacturers register one portal address and let users find the device on it. Whichever you choose, the address in EUDAMED must be the one on the label.
Does the risk class change the duty?
No. Article 7(3) carries no carve out by class. It turns on whether the device uses eIFU instead of paper, and on the date its registration applies.
Are distributors and importers exempt?
Usually the manufacturer registers the device. Under MDR Article 16(1), a distributor or importer that markets a device under its own name, changes its intended purpose or modifies it takes on the manufacturer's obligations, and the EUDAMED record comes with them.
How is swissdamed different from EUDAMED?
Swissmedic states that device, system and procedure pack registration became mandatory in swissdamed on 1 July 2026, with a transition period until 31 December 2026. Economic operator registration has applied in Switzerland since 26 November 2021 and runs in swissdamed since August 2024. A EUDAMED record creates no Swiss record, so a device sold in both markets is registered twice.
Which sources was this guide checked against?
What is Matrix eIFU, and how does it handle the EUDAMED address?
Matrix eIFU is a white label electronic instructions for use service for medical device and IVD manufacturers: users reach the instructions on the manufacturer's own branded site in three clicks. Plans start at 420 euros a month for three product lines, with unlimited products and IFU documents, according to the Matrix eIFU product page read on 10 November 2026.
The EUDAMED readiness page describes UDI linking structured to match EUDAMED data requirements, eIFU URLs structured for EUDAMED, and platform updates as modules activate. The EU MDR compliance page adds branded eIFU URL and QR code generation for labelling and paper on demand fulfilment with an audit trail. Because the platform is software in your quality system, ISO 13485 clause 4.1.6 asks you to validate it, and clause 7.4 to qualify the vendor; the product page lists validation report templates for that.
Above: a Matrix eIFU portal page, as shown on the Matrix eIFU product page. One device identifier carries its instructions for use, reprocessing instructions and SSCP on separate tabs, with country and language selectors at the top. The portal address is what goes on the label and into EUDAMED.
Real feedback from a regulatory affairs manager at an orthopaedic device manufacturer in Switzerland, published on our product page: moving to eIFU ended printing orders, shipping paper to warehouses, holding paper stock and replacing outdated versions. The same manager called the switch a change management process on several levels.
What do you need in place before Matrix eIFU works?
Your master IFU list: one product line is one master IFU, with its translations included.
The target markets and the language each Member State requires (Article 5(11) of 2021/2226).
Your EUDAMED registration plan: actor registration done and the UDI-DIs the eIFU address will attach to.
The label artwork change that prints the eIFU address under Article 6(2).
A named owner for paper requests and for monitoring the address over the 10 or 15 year period.
Moving off a homegrown portal adds a step. Our migration page lists bulk import of existing IFU documents and metadata, URL redirect support so existing labels keep working, a parallel running period and validation documentation for your change control.
What is Matrix eIFU built for, and what would you run alongside it?
Matrix eIFU is built to host, version and publish the instructions and to keep the address you register stable. It does not design your labels. The label that carries the address comes out of an artwork and labelling system, the core strength of platforms such as Kallik, whose own site describes cloud based labeling and artwork management software for regulated industries. For how the hosting options compare, see our eIFU hosting providers comparison, and for the labelling rules, eIFU, labels and IFU under the MDR.
Summary: how do you register your eIFU URL in EUDAMED?
If an MDR device uses eIFU instead of paper, Article 7(3) of Regulation (EU) 2021/2226 requires the eIFU address printed on its label to go into the EUDAMED UDI database under Annex VI, Part B, point 22. New devices carry it from registration, mandatory since 28 May 2026; devices already on the market must be registered by 28 November 2026; the address must then work for 10 or 15 years. Matrix eIFU is the hosting service we build to keep it stable. The three things that matter most:
Enter the label address in the point 22 field of every UDI-DI that uses eIFU instead of paper (Article 7(3)).
Finish devices first sold before 28 May 2026 by 28 November 2026, and swissdamed by 31 December 2026.
Keep the address stable and directly accessible for the full Article 5(9) and 5(10) period.
For which eIFU platforms do this best, see our best eIFU software ranking.
Last updated: 10 November 2026.
Registering your eIFU URL in EUDAMED: frequently asked questions
In the UDI/Device module, in the device record field defined by Annex VI, Part B, point 22 of the MDR: "URL for additional information, such as electronic instructions for use". Article 7(3) of Regulation (EU) 2021/2226 names that point.
Annex VI marks point 22 as optional. Article 7(3) of 2021/2226, added by 2025/1234, makes it compulsory for a manufacturer that provides instructions in electronic form instead of paper. Where full paper instructions ship with the device, Article 9 only asks that any eIFU be consistent with them.
28 November 2026, for a device whose first unit was placed on the EU market before 28 May 2026 and which is still being placed. That is 12 months after the 27 November 2025 notice, per the Commission's EUDAMED Q&A and transition timeline.
For devices with an expiry date, other than implants, 10 years after the last device is placed on the market and at least 2 years after the expiry date of the last device produced. For implants and devices without an expiry date, 15 years (Article 5(9) and 5(10), read with Article 7(2)(e)).
Yes, if you sell in Switzerland. Swissmedic made device registration in swissdamed mandatory from 1 July 2026, with a transition period until 31 December 2026, and a EUDAMED record does not create a Swiss one.
You can, but the address has to stay stable for 10 or 15 years, the site must meet Article 7(2) of 2021/2226, and as quality system software it needs validation under ISO 13485 clause 4.1.6. Our migration page lists what moving off a homegrown portal involves, including URL redirects so printed labels keep working.
The Matrix eIFU product page prices by product line: plans start at 420 euros a month for three product lines, with unlimited products and IFU documents. Corrected versions and translations run through the version management and website translation modules.
Request a demo and get started today.
See how Matrix One connects your requirements, risks, tests, and documentation in one platform.
Thank you
A member of our team will be in contact within 48 hours.